ArticleObesity surgery2026
Long-Term Outcomes up to 10 Years After Indication-Based Conversion to One-Anastomosis Gastric Bypass or Roux-En-Y Gastric Bypass Following Sleeve Gastrectomy.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSleeve gastrectomy (SG) is the most performed bariatric surgery worldwide. Over time, conversion may be required for refractory weight recurrence (WR), gastroesophageal reflux disease (GERD), or both. This study evaluated indication-based conversion outcomes after SG.
methodsAt a single center, 576 SG procedures were performed between 2007 and 2019. Procedure selection was predefined: one-anastomosis gastric bypass (OAGB) for WR without GERD, and Roux-en-Y gastric bypass (RYGB) for GERD with or without WR. Follow-up included weight measurements and upper gastrointestinal endoscopy at 1, 5, and 10 years. Ten-year analyses were restricted to patients converted between 2007 and 2014. Weight-loss analyses excluded isolated GERD conversions.
resultsFollow-up after primary SG was available in 423/576 patients at 1 year and 283/576 at 5 years. Among patients with 5-year follow-up, 87/283 underwent conversion: 43 to RYGB and 44 to OAGB. Mean total weight loss (TWL) after RYGB was 31.2%, 23.5%, and 21.6% at 1, 5, and 10 years; after OAGB, it was 32.8%, 29.9%, and 27.4%. At 10 years, TWL data were available for 4 RYGB and 18 OAGB patients. GERD with esophagitis after conversion was observed after RYGB in 2/43, 1/41, and 1/9 patients at 1, 5, and 10 years, and after OAGB in 0/43, 0/42, and 0/18.
conclusionIn this indication-based cohort, OAGB showed sustained TWL after conversion for WR without GERD, whereas RYGB provided reflux control in most GERD conversions. Between-procedure differences were descriptive, reflecting non-randomized allocation and small 10-year denominators.
Indexed as
Identifiers
42581263What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.